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The unprecedented resolution of high-throughput genomics has enabled the recent discovery of
a phenomenon by which specific regions of the genome are shattered and then stitched together
via a single devastating event, referred to as chromothripsis. Potential mechanisms governing
this process are now emerging, with implications for our understanding of the role of genomic
rearrangements in development and disease.Structural variation in the human genome has warranted consid-
erable interest in the cancer community due to the potential
functional consequences of these rearrangements in tumorigen-
esis. Through the acquisition of genomic rearrangements over
time, a cell may tolerate the disruption of tumor suppressor
genes, activation of oncogenes, or generation of fusion proteins
that individually (or in combination) can promote tumor progres-
sion. Furthermore, the restricted expression of many resulting
somatic gene fusions exemplifies the potential for discovering
and developing novel targeted therapies. A recent discovery is
the phenomenon whereby tens to hundreds of chromosomal
rearrangements localized to a limited number of genomic
regions can be acquired in a single catastrophic event termed
chromothripsis (Greek, chromos for chromosome; thripsis, shat-
tering into pieces) (Stephens et al., 2011). Cells that can survive
such a catastrophic event emerge with a highly mutated
genomic landscape that can confer a significant selective advan-
tage to the clone, thereby promoting cancer progression. Initial
screening indicates that chromothripsis is a widespread
phenomenon occurring in 2%–3% of different cancer types
with some variability, as exemplified by the higher frequency
observed in bone cancers. In addition to tumorigenesis, chromo-
thripsis also appears to be playing a role during normal human
development. Though the mechanisms behind chromothripsis
are not yet fully understood, observations from recent work
have provided some insights into the process.
Chromothripsis occurs through a single catastrophic shatter-
ing event followed by the stitching of genomic fragments into
derivative chromosomes (Figure 1). Closer inspection of the
phenomenon resulted in the formulation of six features that
comprise a ‘‘signature of chromothripsis.’’ These criteria are as
follows: (1) multiple and complex rearrangements primarily alter
a single chromosome, chromosomal arm, or region and, in some
instances, concurrent rearrangements between chromosomes;
(2) many regions show copy number changes alternating
between two states, one copy (heterozygous deletion) or two
copy (no loss or gain); (3) regions of single copy are not neces-sarily from simple deletions but are the byproduct of complex re-
arrangements spanning the region; (4) pronounced clustering of
breakpoints; (5) the fragments residing in the clustered break-
point regions do not reside in close proximity in the germline;
and (6) breakpoints involving multiple chromosomes also show
clustering. Subsequent cytogenetic confirmation suggests that
genomic breakpoint clustering is not due to multiple, parallel
rearrangements from various subclones (Stephens et al., 2011).
Implications of Chromothripsis in Cancer
Though the initial observation wasmade in a patient with chronic
myeloid leukemia, additional screening revealed that 2%–3%
of patients across a broader range of human cancers show signs
of chromothripsis. As a first pass, Stephens et al. screened
single-nucleotide polymorphism (SNP) array data from 746
cancer cell lines, revealing 18 cell lines with genomic landscapes
harboring the hallmarks of chromothripsis. In addition to hemato-
logical malignancies, this cell line subset included melanoma,
lung, glioma, sarcoma, esophageal, colorectal, renal, and thyroid
cancer. It is possible that this is an underrepresentation, as the
heterogeneity in primary tumorsmay disguise the chromothripsis
signature; closer examination of specific cancer typesmay show
more variable rates. A recent study confirms the prevalence of
chromothripsis in multiple myeloma (MM) and suggests that
chromothripsis may be associated with a poor outcome in MM
(Magrangeas et al., 2011). Recent work by Rausch et al. in this
issue of Cell (Rausch et al., 2012) examined copy number data
for 311AMLpatients and founda significant association between
chromothripsis andpoor prognosis. Lastly, on ananecdotal level,
the 62-year-old CLL patient from which chromothripsis was
initially observed also showed rapid deterioration and relapsed
quickly despite receiving alemtuzumab, a monoclonal antibody
used in the treatment of CLL (Stephens et al., 2011).
The association of chromothripsis with more aggressive
tumors is quite logical given the potential impact that a single
catastrophic event may have on a cell. A progressive model of
tumor cell evolution suggests the gradual accumulation ofCell 148, January 20, 2012 ª2012 Elsevier Inc. 29
Figure 1. Chromothripsis Reshapes the Genomic Landscape in a Single Devastating Event
Overview of chromothripsis. Stress stimulus may help to trigger the shattering process in localized regions that are subsequently stitched back together. (Left)
Stress simultaneously generates double-strand breaks (triangle) that are joined together to generate a derivative chromosome, potentially resulting in regions
being deleted. The breakpoint junction reveals microhomology, without insertions, thereby supporting NHEJ. (Right) A replicative stress generates a nick in the
chromosome, causing a replication fork to collapse. MMBIR results in the duplication and triplication represented by two or three rectangles above the altered
chromosome, respectively. An example breakpoint junction reveals microhomology as well as a short insert.mutations randomly throughout the genome over time. However,
shattering a genome into tens to hundreds of fragments and then
stitching them back together, in a seemingly random process,
produces highly derivative chromosomes. This can result in the
concurrent generation of numerous mutations that individually,
or in combination, provide a selective advantage for a cell. As
such, it is believed that chromothripsis can accelerate the evolu-
tionary process of a tumor cell.
Multiple lines of evidence have been proposed to support
a single catastrophic event versus a progressive model. First,
the number of copy number states following chromothripsis is
predominantly restricted to two states. Under a progressive
model, the number of states would be expected to increase
during the accumulation of rearrangements. To further support
this, Stephens et al. performed a Monte Carlo simulation of the
progressive model of acquiring rearrangements to demonstrate
that a cell harboring the observed quantity of breakpoints in four
samples having undergone chromothripsis (SNU-C1, PD3172,
8505C, and TK10) should have resulted in more copy number
states. Second, regions with higher copy number retain hetero-
zygosity following chromothripsis. However, under a progressive
model, an early occurring deletion would eliminate heterozy-
gosity. Third, under a progressive model, a random distribution
of rearrangements would be expected. This is in sharp contrast
to the high level of breakpoint clustering, suggesting a single
catastrophic event. Overall, given the interrelatedness of the
rearrangements and spatial localization, it is unlikely that the
signature originated from independent, consecutive events.30 Cell 148, January 20, 2012 ª2012 Elsevier Inc.Recent work by Rausch et al. using whole-genome
sequencing (WGS) and array-based approaches has revealed
a link between both germline and somatic TP53 mutations and
chromothripsis. WGS of a Sonic-Hedgehog subtype of medullo-
blastoma (SHH-MB) from a female patient with Li-Fraumeni
syndrome (LFS), a disorder with germline TP53 mutations that
increase susceptibility to cancer, revealed a signature of chro-
mothripsis. Furthermore, germline DNA, available for six of the
ten SHH-MB patients showing signs of chromothripsis, was
used to confirm five patients with germline TP53 mutations.
These five patients represent previously undiagnosed LFS
cases. Overall, germline mutations of TP53 in SSH-MB patients
suggest that it occurred prior to chromothripsis and may be
involved in the initiation and/or response to chromothripsis.
Chromothripsis and Human Development
Two recent studies have suggested that chromothripsis may
also contribute to structural variation in the germline. In the first
study, a family trio that includes a child with severe congenital
abnormalities underwent mate-pair sequencing. This work
provided evidence that chromothripsis may be generating struc-
tural variation in the germline that results in congenital defects
(Kloosterman et al., 2011a). In the second study, 17 individuals
showing developmental delay and cognitive anomalies were
analyzed with array comparative genomic hybridization (aCGH)
and breakpoint sequencing, resulting in the observation of
a mechanism similar to chromothripsis. This suggests that cata-
strophic events may be occurring throughout the life cycle of an
organism (Liu et al., 2011). Furthermore, in addition to the inver-
sions and translocations that had previously been associated
with chromothripsis, the individuals showed extensive duplica-
tion and triplication. These differences in the observed altered
chromosomes between Stephens et al. and Liu et al. are sugges-
tive of differences in the cause andmechanism of repair. Overall,
it is clear that chromothripsis plays a significant role in human
development, and through the advancement of recent technolo-
gies, we can begin to dissect the potential mechanisms.
Mutational Mechanisms Governing the ‘‘Shattering’’
Process
Three areas that will garner significant interest in discovering the
underlying causes of chromothripsis are the genomic localiza-
tion, the mechanism driving the shattering process, and the
stitching of the fragmented segments.
Existing data have shown that the shattering appears to
involve only a subset of chromosomes, a single chromosome,
a chromosomal arm, or even a fewmegabases of a chromosomal
band. Though it seems puzzling, the localization of the shattered
genomic fragments may offer a few possibilities as to the
mechanism. For instance, the ability to accomplish such con-
fined damage, exemplified by high-density breakpoint clusters,
suggests that the chromosomes are likely condensed, and
therefore the shattering event may occur during mitosis. Further-
more, instances involving multiple chromosomes suggest
a spatial proximity during the shattering event, resulting in the
random stitching confined to a subset of chromosomes. Though
it is astounding that a cell can survive such a catastrophic event,
it is plausible that localized shattering represents the upper
limit of what a cell can tolerate and still survive. Therefore, a con-
trasting view is that chromothripsis events are not always
restricted to specific regions; however, any event involving a
greater number of chromosomes may have had lethal conse-
quences and therefore is not observed.
The mechanisms driving chromosomal translocations have
been a major area of interest in cancer biology, and therefore
understanding the shattering process poses a new challenge. It
is unclear what caused the double-stranded DNA breaks, but
an environmental stimulus, such as free radicals or ionizing
radiation, may serve as the trigger (Lieber, 2010; Tsai and Lieber,
2010). For instance, exposure to ionizing radiationwhile the chro-
mosomes are condensed during mitosis would offer an opportu-
nity to intensely shatter a localized region froma chromosome, or
multiple chromosomes, in close spatial proximity.
DNA replication stress may serve as a stimulus to chromothrip-
sis. This can occur through an increase in the number of stalled
DNA replication forks by inhibitory agents of DNA replication or
decreased stability of stalled forks by altered DNA replication
checkpoint proteins. Interestingly, it has been shown that precan-
cerous cells with activated oncogenes have prematurely termi-
nated DNA replication forks and DNA DSBs that form specifically
in S phase. Regardless of the specific DNA replication stress,
a DNA replication fork collapse at a specific chromosomal loci,
potentially a common fragile site, can generate the genomic
configurations associated with chromothripsis (Halazonetis et al.,
2008). Further, recentworkbyCrastaet al. shows thatmicronuclei,
generated from mitotic chromosome segregation errors, havepersistent DNA replication (Crasta et al., 2012). The authors go
on to show that aberrant DNA replication can produce DNA
damage and mutagenesis or chromosome pulverization within
the micronuclei. As observed during chromothripsis, the partition-
ingofachromosome intomicronuclei alsooffers anexplanation for
extensive DNA damage being restricted to a single chromosome.
As the shattering typically involves the telomeric region, there
may be a link to telomere shortening, suggesting a breakage-
fusion-bridge cycle (Pampalona et al., 2010). Following telomere
loss, end-to-end chromosome fusions form and are subse-
quently pulled to opposite daughter cells via their centromeres,
thereby forming the anaphase bridge (McClintock, 1941; Sahin
and Depinho, 2010). Though this model offers a mechanism for
potential localization, it is typically associated with amplicons,
or regions of high copy number, and results in head-to-head
duplications, whereas chromothripsis produces highly complex
derivative chromosomeswith two or three copy states (Murnane,
2006; O’Hagan et al., 2002).
Interestingly, the shattering observed during chromothripsis
shows similarities to the dramatically altered chromosomes
involved in the previously characterized process of premature
chromosome compaction (PCC) (Rao and Johnson, 1970; Sperl-
ing and Rao, 1974). The process of PCC has been shown to
occur when chromosomes from an S phase nucleus are induced
to undergo chromosome condensation by signals from chromo-
somes derived from mitosis. This, in turn, results in the ‘‘shatter-
ing’’ of the incompletely replicated chromosomes. Given the
similarities in the intense genomic disruption, it is plausible that
chromothripsis could be due to a similar process.
A different perspective is that chromothripsis might be caused
by an apoptoticmechanism (Tubio and Estivill, 2011). Here, a cell
would undergo apoptosis due to the stress of an external
stimulus, such as ionizing radiation. Though the majority of cells
would ultimately die, a subset of the population may survive and
subsequently undergo DNA repair that can introduce rearrange-
ments (Stanulla et al., 2001). Overall, several models have been
proposed, additional experimental work is necessary to fully
elucidate the specific mechanism(s).
Given the importance of TP53 for maintaining genomic
stability, the recent work by Rausch et al. suggests that TP53
mutations may predispose cells to chromothripsis. This can be
exemplified by its potential role in a number of the proposed
mechanisms. For instance, if the chromothripsis is driven by
the generation of DSBs following exposure to ionizing radiation,
a cell harboring TP53 mutations may show a preference toward
low-fidelity repair mechanisms such as nonhomologous end-
joining (NHEJ). In the context of telomere shortening, cells with
mutant TP53 are likely to show an increased delay at the G2/M
transition and shorter telomeres and are more prone to end-to-
end fusions. Lastly, mutant TP53 may contribute to altered
control of the G2/M transition checkpoint, thereby contributing
to premature chromosome compaction. In addition to contrib-
uting to the mechanism driving chromothripsis, impaired TP53
may also facilitate cell survival following a catastrophic event.
Stitching Chromosomes Back Together
Independent of the mechanism causing chromothripsis, exami-
nation of the resulting genomic features in conjunction withCell 148, January 20, 2012 ª2012 Elsevier Inc. 31
nucleotide resolution of the breakpoint junctions, from high-
throughput sequencing, offers some insights into how the frag-
ments are joined together (Figure 1). The first mechanism is
NHEJ, a template-independent DNA double-strand break repair
mechanism that ligates twobrokenDNAendswith a concomitant
loss or gain of nucleotides (Lieber, 2010). In addition to NHEJ,
replicative processes have been associated with the generation
of complex genomic rearrangements such as fork stalling
template switching (FoSTeS) and microhomology-mediated
break-induced repair (MMBIR). MMBIR is based on the notion
that the replication fork collapses when it encounters a nick, or
single-strand break, and has therefore been the more supported
mechanism attributed to the observed chromothripsis events
(Hastings et al., 2009). The breakpoint junctions derived from
replicative processes are expected to have microhomologies,
insertions, and relatively long templated insertions. Furthermore,
in contrast to NHEJ repair of simultaneously generated DSBs,
replicative processes offer an explanation for the duplications
and triplications that have been reported (Liu et al., 2011).
To date, the breakpoints generated via chromothripsis in
human cancer appeared to have limited sequence overlap,
thereby suggesting that, following shattering, via double-
stranded DNA breaks, genomic fragments were stitched
together by an NHEJ mechanism, as opposed to homologous
recombination, to form complex derivative chromosomes. For
instance, the breakpoint junctions from LFS SHH-MB cases
revealed short (less than four base pairs) microhomology tracts
and instances of short insertions of nontemplate DNA sequence
consistent with NHEJ. The reassembly of the derivative chro-
mosomes may be guided by microhomology or is completely
random and based on the spatial proximity of the genomic
fragments (Kloosterman et al., 2011b; Stephens et al., 2011).
In contrast to somatic alterations that occur in differentiated
cells, germline rearrangements discovered in genomic disorders
were found to occur during gametogenesis or early postzygotic
development. Kloosterman et al. observed patterns among the
breakpoints, indicative of simultaneous double-stranded breaks
in patients with congenital abnormalities. The breakpoint junc-
tions revealed microhomology, a lack of homology, or small
insertions and deletions, supporting a nonhomologous mecha-
nism of break repair. In contrast, Liu et al. observed small
template insertions and microhomology at the breakpoint junc-
tions, suggestive of a replicative process such as FoSTeS (Lee
et al., 2007) or MMBIR (Hastings et al., 2009). Overall, though
initial studies suggest that NHEJ seems to be a predominant
model in somatic structural variation, our understanding of the
stitching process in human development remains an area of
significant research.
Impact on Patient Care
Only through additional screening across larger patient cohorts
will there be sufficient strength to establish clinical associations
with patients having undergone chromothripsis. However, some
headway into the contributing factors of chromothripsis has
already been made, as exemplified by the high incidence of
chromothripsis in SHH-MB patients with TP53 mutations,32 Cell 148, January 20, 2012 ª2012 Elsevier Inc.many of which are germline TP53 mutations. Furthermore, this
association is not restricted to medulloblastoma, as preliminary
evidence shows that, in LFS patients, excluding SSH-MB, chro-
mothripsis occurs at a higher rate (36%) than overall incidence in
cancers (2%–3%) (Rausch et al., 2012). This is clinically signifi-
cant in that these patients may benefit from regular screening
and may warrant careful treatment strategies involving DNA-
damaging agents and radiotherapy in order to reduce the inci-
dence of therapy resistance and ultimately increase survival
rates. Chromothripsis demonstrates how the analysis of large-
scale genomics data can have profound effects on human devel-
opment and tumor cell progression.
ACKNOWLEDGMENTS
C.A.M. is funded by an NIH grant R00CA149182-03 and a Prostate Cancer
Foundation Young Investigator Award.
REFERENCES
Crasta, K., Ganem, N.J., Dagher, R., Lantermann, A.B., Ivanova, E.V., Pan, Y.,
Nezi, L., Protopopov, A., Chowdhury, D., and Pellman, D. (2012). Nature. Pub-
lished online January 18, 2012. 10.1038/nature10802.
Halazonetis, T.D., Gorgoulis, V.G., and Bartek, J. (2008). Science 319, 1352–
1355.
Hastings, P.J., Ira, G., and Lupski, J.R. (2009). PLoS Genet. 5, e1000327.
Kloosterman, W.P., Guryev, V., van Roosmalen, M., Duran, K.J., de Bruijn, E.,
Bakker, S.C., Letteboer, T., van Nesselrooij, B., Hochstenbach, R., Poot, M.,
and Cuppen, E. (2011a). Hum. Mol. Genet. 20, 1916–1924.
Kloosterman, W.P., Hoogstraat, M., Paling, O., Tavakoli-Yaraki, M., Renkens,
I., Vermaat, J.S., van Roosmalen, M.J., van Lieshout, S., Nijman, I.J., Roes-
singh, W., et al. (2011b). Genome Biol. 12, R103.
Lee, J.A., Carvalho, C.M., and Lupski, J.R. (2007). Cell 131, 1235–1247.
Lieber, M.R. (2010). Annu. Rev. Biochem. 79, 181–211.
Liu, P., Erez, A., Nagamani, S.C., Dhar, S.U., Ko1odziejska, K.E., Dharmadhi-
kari, A.V., Cooper, M.L., Wiszniewska, J., Zhang, F., Withers, M.A., et al.
(2011). Cell 146, 889–903.
Magrangeas, F., Avet-Loiseau, H., Munshi, N.C., and Minvielle, S. (2011).
Blood 118, 675–678.
McClintock, B. (1941). Genetics 26, 234–282.
Murnane, J.P. (2006). DNA Repair (Amst.) 5, 1082–1092.
O’Hagan, R.C., Chang, S., Maser, R.S., Mohan, R., Artandi, S.E., Chin, L., and
DePinho, R.A. (2002). Cancer Cell 2, 149–155.
Pampalona, J., Soler, D., Genesca`, A., and Tusell, L. (2010). Mutat. Res. 683,
16–22.
Rao, P.N., and Johnson, R.T. (1970). Nature 225, 159–164.
Rausch, T., Jones, D.T.W., Zapatka, M., Stutz, A.M., Zichner, T., Weischen-
feldt, J., Jager, N., Remke, M., Shih, D., Northcott, P.A., et al. (2012). Cell
148, this issue, 59–71.
Sahin, E., and Depinho, R.A. (2010). Nature 464, 520–528.
Sperling, K., and Rao, P.N. (1974). Chromosoma 45, 121–131.
Stanulla, M., Chhalliyil, P., Wang, J., Jani-Sait, S.N., and Aplan, P.D. (2001).
Hum. Mol. Genet. 10, 2481–2491.
Stephens, P.J., Greenman, C.D., Fu, B., Yang, F., Bignell, G.R., Mudie, L.J.,
Pleasance, E.D., Lau, K.W., Beare, D., Stebbings, L.A., et al. (2011). Cell
144, 27–40.
Tsai, A.G., and Lieber, M.R. (2010). BMC Genomics 11 (Suppl 1), S1.
Tubio, J.M., and Estivill, X. (2011). Nature 470, 476–477.
